Dr. Martens plc (LON:DOCS - Get Free Report) shares traded up 25.8% on Thursday . The company traded as high as GBX 76 ($1.03) and last traded at GBX 75.40 ($1.02). 8,364,149 shares changed hands during trading, an increase of 271% from the average session volume of 2,253,765 shares. The stock had previously closed at GBX 59.95 ($0.81).
Analyst Upgrades and Downgrades
Separately, Royal Bank of Canada lowered their target price on shares of Dr. Martens from GBX 7,000 ($94.86) to GBX 6,000 ($81.31) and set a "sector perform" rating for the company in a research note on Monday, May 19th.
Read Our Latest Research Report on Dr. Martens
Dr. Martens Stock Performance
The company has a market capitalization of £751.86 million, a price-to-earnings ratio of 10.98, a PEG ratio of 6.40 and a beta of 0.11. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The stock has a 50 day simple moving average of GBX 55.34 and a two-hundred day simple moving average of GBX 62.91.
Dr. Martens (LON:DOCS - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) EPS for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. As a group, analysts anticipate that Dr. Martens plc will post 2.5809394 earnings per share for the current year.
Dr. Martens Cuts Dividend
The business also recently declared a dividend, which was paid on Tuesday, April 8th. Investors of record on Thursday, March 6th were issued a dividend of GBX 0.85 ($0.01) per share. This represents a dividend yield of 1.47%. The ex-dividend date of this dividend was Thursday, March 6th. Dr. Martens's dividend payout ratio is presently 42.53%.
Insider Transactions at Dr. Martens
In other news, insider Giles Wilson bought 32,640 shares of the stock in a transaction on Tuesday, March 25th. The shares were bought at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,886.16). In the last quarter, insiders bought 33,206 shares of company stock worth $1,792,771. Company insiders own 4.36% of the company's stock.
Dr. Martens Company Profile
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Featured Articles
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
